Last reviewed · How we verify
levobupivacaine bolus dosing
Levobupivacaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and propagation of action potentials.
Levobupivacaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and propagation of action potentials. Used for Local and regional anesthesia for surgical procedures, Infiltration anesthesia, Peripheral nerve blocks.
At a glance
| Generic name | levobupivacaine bolus dosing |
|---|---|
| Also known as | bolus group |
| Sponsor | Kuopio University Hospital |
| Drug class | Local anesthetic (amide) |
| Target | Voltage-gated sodium channels |
| Modality | Small molecule |
| Therapeutic area | Anesthesia/Pain Management |
| Phase | FDA-approved |
Mechanism of action
Levobupivacaine is the S-enantiomer of bupivacaine, a long-acting amide local anesthetic. It works by reversibly binding to and blocking voltage-gated sodium channels on the inner surface of nerve cell membranes, thereby preventing depolarization and transmission of nerve impulses. The S-enantiomer formulation offers improved cardiac safety compared to the racemic mixture while maintaining local anesthetic efficacy.
Approved indications
- Local and regional anesthesia for surgical procedures
- Infiltration anesthesia
- Peripheral nerve blocks
- Epidural anesthesia
Common side effects
- Hypotension
- Bradycardia
- Dizziness
- Nausea
- Headache
- Paresthesia
- Systemic toxicity (CNS/cardiac)
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- levobupivacaine bolus dosing CI brief — competitive landscape report
- levobupivacaine bolus dosing updates RSS · CI watch RSS
- Kuopio University Hospital portfolio CI